At this year’s START Summit, Xeltis’ CEO Laurent Grandidier will share insights on how he drove Xeltis’ transformation from research entity into one of the most promising medtech start-ups. He is the mastermind behind an oversubscribed €45 million Series C fundraiser, the largest in European medtech in 2017, that will help catapult Xeltis’ strategy forward and accelerate its aortic and pulmonary valve programs.
“Spotting the distinctive traits of a potentially successful start-up, turning a promising technology into successful products and selecting the right investors are entrepreneurial skills that proved fundamental at Xeltis,” explained Grandidier. “I look forward to sharing my insights with young start-up founders and entrepreneurs, and get inspired by their fast and creative minds,” he added.
Laurent Grandidier is an MBA graduate from business school INSEAD and, in his own words, “200% entrepreneur.” Follow him at START Summit today at 11:45am on the Main Stage.
The START Summit is Europe’s leading student-led conference for entrepreneurship and technology. This year, it is expected to gather over 2,000 young entrepreneurs, investors, high-profile speakers and tech influencers from around the world.
For more information on Laurent Grandidier, please visit his CEO Profile.
